MedTrace Logo

Effect of Midazolam as Premedication in Patients Undergoing Breast Conservation Study

NCT07184125 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 124

Last updated 2026-01-08

No results posted yet for this study

Summary

Patient are randomized into 2 groups under computer registered numbers. Patient anxiety score is calculated through APAIS SCORE. Then one group is given Midazolam, and the other group is given normal saline and then after one day patients satisfaction is calculated through Lppsq scale.

Conditions

Interventions

DRUG

To measure anxiolysis, satisfaction level of patient after receiving Midazolam

Anxiety \& satisfaction

Sponsors & Collaborators

  • Shaukat Khanum Memorial Cancer Hospital & Research Centre

    lead OTHER

Principal Investigators

  • Dr. Mehwish Shafique, MBBS, FCPS Anesthesia · Shaukat Khanam Cancer Memorial Hospital & Research Centre

Eligibility

Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-30
Primary Completion
2025-09-10
Completion
2025-09-10

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07184125 on ClinicalTrials.gov